IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on October 30, 2019. The filing serves to announce the Company's financial results for the third quarter ended October 30, 2019. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on the NASDAQ Capital Market under the symbol IRMD.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial data and analysis.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific Q3 2019 financial figures.
- Verify year-over-year and quarter-over-quarter performance metrics not detailed in this summary.
- Confirm any forward-looking statements or guidance provided in the press release.
- Check for any updates on the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.